AN UNBIASED VIEW OF TEMAZEPAM

Coadministration with CYP3A4 substrates, specifically All those having a slender therapeutic index, can lead to lessened concentrations and loss of efficacy. If unable to stay clear of coadministration, monitor CYP3A4 substrate ranges and adjust dose as necessary.Stiripentol can be a CYP3A4 inhibitor and inducer. Observe CYP3A4 substrates coadminis